Epidemiology and outcomes of non-alcoholic fatty liver disease in African Americans [0.03%]
美国非裔人群的非酒精性脂肪肝病的流行病学和转归情况
Kenneth W Chow,Mark Ebaid,Brittney M Ibrahim et al.
Kenneth W Chow et al.
1_bxolhs28Kaltura. Copyright © 2023 American Association for the Study of Liver Diseases.
Psychological interventions to treat alcohol use disorder in patients with liver disease [0.03%]
针对肝病患者酒精使用障碍的心理治疗方法
Samhita Ravi,Maria Hernandez-Tejero,Hugo Lopez-Pelayo et al.
Samhita Ravi et al.
A pilot study to understand and respond to loss, theft, and misplacement of hepatitis C treatment medication for people who inject drugs [0.03%]
一项试点研究了解和应对注射吸毒者在丙型肝炎治疗过程中出现的药物遗失、被盗或放置错误的问题
Meghan D Morris,Claire McDonell,Rebecca G Kim et al.
Meghan D Morris et al.
1_som2wbs2Kaltura. Copyright © 2023 American Association for the Study of Liver Diseases.
Prevalence of depression and anxiety symptoms by liver disease etiology [0.03%]
不同病因肝病患者抑郁和焦虑症状的流行状况
Todd Doyle,Benjamin Schmidt,Steve Scaglione
Todd Doyle
Noninvasive tests in the evaluation of nonalcoholic fatty liver disease: A review [0.03%]
非酒精性脂肪肝病评估的无创检测方法：综述
Kyaw Min Tun,Nabil Noureddin,Mazen Noureddin
Kyaw Min Tun
1_kpnc0f20Kaltura. Copyright © 2023 American Association for the Study of Liver Diseases.
Epidemiology and trends of alcohol use disorder and alcohol-associated liver disease [0.03%]
饮酒障碍和酒精相关肝病的流行病学及发病趋势
Elizabeth Lee,Huttakan Navadurong,Suthat Liangpunsakul
Elizabeth Lee
1_vx2q4xfhKaltura. Copyright © 2023 American Association for the Study of Liver Diseases.
Direct oral anticoagulants in the treatment of portal vein thrombosis in patients with portal hypertension [0.03%]
直接口服抗凝药在门脉高压患者门静脉血栓形成治疗中的应用
Kevin Tang,Ethan M Weinberg
Kevin Tang
Frances Lee,Tarun Rustagi,R Todd Frederick
Frances Lee
Apoorva Gogna,Hiang Keat Tan,Chow Wei Too et al.
Apoorva Gogna et al.
Maria Mironova,Christopher Koh,Theo Heller
Maria Mironova